COVID-19 Vaccine Development Tools Market Size Report, Growth, Forecast, 2032

COVID-19 Vaccine Development Tools Market

COVID-19 Vaccine Development Tools Market - By Technology (Lab Technologies, PCR & qPCR, Flow Cytometry, Spectrometry, Electron Microscopy, and Next Generation Sequencing), By End-Use (CROs and Pharma & BioPharma Firms), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Biotechnology Report Format : PDF Pages: 160 Report Code: ZMR-6528 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 7.12 Billion USD 15.46 Billion 9% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. COVID-19 Vaccine Development Touls Market, 2018–2028(USD Billion)
    • 2.2. COVID-19 Vaccine Development Touls Market: Snapshot
  • Chapter 3. Global COVID-19 Vaccine Development Touls Market– End-Use Analysis
    • 3.1. COVID-19 Vaccine Development Touls Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Large-scale investment in research & development activities by private & government organizations for developing effective vaccines against COVID-19 will steer market trends.
      • 3.2.2. Humungous utility of AI touls in development of COVID-19 vaccine and surge in strategic alliances & partnerships between various pharma firms facilitating intense research on vaccine development & production will enhance expansion of COVID-19 vaccine development touls market in near future.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Technology
      • 3.4.2. Market attractiveness analysis By End-Use
  • Chapter 4. Global COVID-19 Vaccine Development Touls Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global COVID-19 Vaccine Development Touls Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Technology launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global COVID-19 Vaccine Development Touls Market– Technology Analysis
    • 5.1. Global COVID-19 Vaccine Development Touls Market overview: By Technology
      • 5.1.1. Global COVID-19 Vaccine Development Touls Market share, By Technology, 2020 and 2028
    • 5.2. Lab Technulogies
      • 5.2.1. Global COVID-19 Vaccine Development Touls Market by Lab Technulogies, 2018–2028(USD Billion)
    • 5.3. PCR & qPCR
      • 5.3.1. Global COVID-19 Vaccine Development Touls Market by PCR & qPCR, 2018–2028(USD Billion)
    • 5.4. Flow Cytometry
      • 5.4.1. Global COVID-19 Vaccine Development Touls Market by PCR & qPCR, 2018–2028(USD Billion)
    • 5.5. Spectrometry
      • 5.5.1. Global COVID-19 Vaccine Development Touls Market by Spectrometry, 2018–2028(USD Billion)
    • 5.6. Electron Microscopy
      • 5.6.1. Global COVID-19 Vaccine Development Touls Market by Electron Microscopy, 2018–2028(USD Billion)
    • 5.7. Next Generation Sequencing
      • 5.7.1. Global COVID-19 Vaccine Development Touls Market by Next Generation Sequencing, 2018–2028(USD Billion)
  • Chapter 6. Global COVID-19 Vaccine Development Touls Market– End-Use Analysis
    • 6.1. Global COVID-19 Vaccine Development Touls Market overview: By End-Use
      • 6.1.1. Global COVID-19 Vaccine Development Touls Market share, By End-Use, 2020 and 2028
    • 6.2. CROs
      • 6.2.1. Global COVID-19 Vaccine Development Touls Market by CROs , 2018–2028(USD Billion)
    • 6.3. Pharma & BioPharma Firms
      • 6.3.1. Global COVID-19 Vaccine Development Touls Market by Pharma & BioPharma Firms, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Thermo Fisher Scientific, Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Technology Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Pfizer Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Technology Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Celerion
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Technology Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Sartorius AG
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Technology Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. Cule-Parmer Instrument Company, LLC
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Technology Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. STEMCELL Technulogies Inc.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Technology Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Illumina, Inc.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Technology Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. AB Sciex Private Limited
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Technology Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Agilent Technulogies
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Technology Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Aurora Biomed Inc.
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Technology Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Eurofins Scientific
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Technology Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. PerkinElmer Inc.
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Technology Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Shimadzu Corporation
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Technology Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Merck KgaA
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Technology Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. Qiagen N.V.
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Technology Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development
    • 7.16. Bio-Rad Laboratories, Inc.
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Technology Portfolio
      • 7.16.4. Business Strategy
      • 7.16.5. Recent Development
    • 7.17. Danaher Corporation
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Technology Portfolio
      • 7.17.4. Business Strategy
      • 7.17.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global COVID-19 Vaccine Development Tools Marketattractiveness, By Technology
6. Global COVID-19 Vaccine Development Tools Marketattractiveness, By End-Use
7. Global COVID-19 Vaccine Development Tools Marketshare by Technology ,2020 and 2028 (USD Billion)
8. Global COVID-19 Vaccine Development Tools Marketby Lab Technologies, 2018–2028(USD Billion)
9. Global COVID-19 Vaccine Development Tools Marketby PCR & qPCR, 2018–2028(USD Billion)
10. Global COVID-19 Vaccine Development Tools Marketby Flow Cytometry, 2018–2028(USD Billion)
11. Global COVID-19 Vaccine Development Tools Marketby Spectrometry,  2018–2028(USD Billion)
12. Global COVID-19 Vaccine Development Tools Marketby Electron Microscopy, 2018–2028(USD Billion)
13. Global COVID-19 Vaccine Development Tools Marketby Next Generation Sequencing,  2018–2028(USD Billion)
14. Global COVID-19 Vaccine Development Tools Marketshare by End-Use ,2020 and 2028 (USD Billion)
15. Global COVID-19 Vaccine Development Tools Marketby CROs , 2018–2028(USD Billion)
16. Global COVID-19 Vaccine Development Tools Marketby Pharma & BioPharma Firms, 2018–2028(USD Billion)
17. Global COVID-19 Vaccine Development Tools Marketshare, by Region, 2020 and 2028
18. North America COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
19. Europe COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
20. Asia Pacific COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
21. Latin America COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
22. The Middle East and Africa COVID-19 Vaccine Development Tools Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global COVID-19 Vaccine Development Tools Market: snapshot
2. Drivers of the COVID-19 Vaccine Development Tools Market: impact analysis
3. North America COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
4. North America COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
5. The U.S. COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
6. The U.S. COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
7. Rest of North America COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
8. Rest of North America COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
9. Europe COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
10. Europe COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
11. UK COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
12. UK COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
13. France COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
14. France COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
15. Germany COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
16. Germany COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
17. Rest of Europe COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
18. Rest of Europe COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
19. Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
20. Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
21. China COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
22. China COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
23. Japan COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
24. Japan COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
25. India COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
26. India COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
27. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
28. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
29. Latin America COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
30. Latin America COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
31. Brazil COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
32. Brazil COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
33. Rest of Latin America COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
34. Rest of Latin  America COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
35. The Middle East and Africa COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
36. The Middle East and Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
37. Saudi Arabia COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
38. Saudi Arabia COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
39. South Africa COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
40. South Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa COVID-19 Vaccine Development Tools Market revenue, By Technology  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa COVID-19 Vaccine Development Tools Market revenue, By End-Use  ,2018–2028(USD Billion)


 
 

Methodology

FrequentlyAsked Questions

These tools support vaccine research and development. They accelerate testing, analysis, and production

The global COVID-19 Vaccine Development Tools market is expected to be driven by the ongoing vaccine R&D, variant monitoring, and preparedness initiatives. Demand for rapid development and testing tools supports market growth.

According to study, the global COVID-19 Vaccine Development Tools market size was worth around USD 7.12 Billion in 2023 and is predicted to grow to around USD 15.46 Billion By 2032.

The global COVID-19 Vaccine Development Tools market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 9% during the forecast period from 2024-2032.

The global COVID-19 Vaccine Development Tools industry is projected to be challenged by Challenges include reduced emergency funding and shifting R&D priorities.

The Opportunities include platform reuse for new vaccines, mRNA and viral vector innovation, pandemic preparedness, and infectious disease research will offer significant growth opportunities in the COVID-19 Vaccine Development Tools market.

mRNA and viral vector platform optimization; rapid clinical trial tools; digital modeling and analytics support are the emerging trends and innovations impacting the COVID-19 Vaccine Development Tools market.

The global COVID-19 Vaccine Development Tools market is expected to be led by North America during the forecast period.

Some of the prominent players operating in the global COVID-19 Vaccine Development Tools market are; Thermo Fisher Scientific, Inc., Pfizer Inc., Celerion, Sartorius AG, Cole-Parmer Instrument Company, LLC, STEMCELL Technologies Inc., Illumina, Inc., AB Sciex Private Limited, Agilent Technologies, Danaher Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., Merck KgaA, Shimadzu Corporation, PerkinElmer Inc., Eurofins Scientific, and Aurora Biomed Inc. and others.

The report explores crucial aspects of the COVID-19 Vaccine Development Tools market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

Market InsightsOutlookGrowth DriversReport ScopeRegional LandscapeCompetitive LandscapeThe global Market is segmented as follows:By TechnologyBy End-Use

HappyClients